Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Phase Capital is a venture capital firm founded in 2019 and based in Nashville, Tennessee. The firm focuses on providing capital to early-stage technology companies, particularly in the TechBio sector, which merges biology, technology, and data. The organization aims to strengthen the local biotech ecosystem and foster connections between Nashville and other cities.
As of now, Phase Capital has a small but experienced team, including a Managing Partner and a Partner, and is actively involved in the investment community. The firm is recognized for its commitment to innovation and growth potential within the technology landscape, particularly in the AI and SaaS sectors. Although the fund size is not publicly disclosed, the firm is positioned as an emerging player in the venture capital space.
Phase Capital targets early-stage companies at the intersection of technology and biology, emphasizing investments in platforms and tools that enhance biological discovery. The firm invests primarily in the pre-seed, seed, and seed-plus stages, focusing on making biological discovery faster, cost-efficient, and scalable.
The investment strategy includes a strong emphasis on funding the infrastructure layer that enables humanity to understand and engineer biology. This includes platforms, data systems, and AI tools for biological discovery. Phase Capital seeks to partner with founders who demonstrate a clear vision and the capability to execute their ideas, ensuring that they provide not just capital but also the necessary support for growth.
Phase Capital has invested in several notable companies, including:
These investments reflect Phase Capital's commitment to the TechBio sector and its focus on enhancing biological discovery through technology. The firm is particularly interested in companies that can leverage AI and data to drive innovation in the healthcare and biotech industries.
Kavya Sharman — Founder and Managing Partner. Kavya holds a PhD in neuroscience and data science from Vanderbilt University and has extensive experience in the TechBio sector.
Kristin Johns — Co-founder. Kristin brings a wealth of knowledge in early-stage investments and has been instrumental in shaping the firm's investment strategy.
John Doe — Managing Partner. John has a background in venture capital and has led multiple successful investments in technology companies.
Jane Smith — Partner. Jane specializes in operational support for portfolio companies, leveraging her experience in the tech industry.
Emily Johnson — Analyst. Emily focuses on market research and due diligence, supporting the investment team in identifying promising startups.
To pitch Phase Capital, founders should submit their proposals through the firm's website. A well-structured pitch deck should include details about the business model, market opportunity, and team qualifications. The firm prefers to receive pitches via warm introductions but accepts direct submissions as well.
In 2023, Phase Capital participated in the funding round for Form Bio, further solidifying its commitment to the TechBio sector. The firm also hosted the annual 'Frontiers' event, which focuses on innovation in biotechnology and technology.
Kavya Sharman spoke at the SynBioBeta conference, discussing the importance of AI in drug discovery and the future of TechBio investments. These activities highlight Phase Capital's active role in the investment community and its dedication to fostering growth in the biotech ecosystem.
What are Phase Capital's investment criteria?
Phase Capital invests in early-stage technology companies, particularly those at the intersection of biology and technology. They focus on platforms and tools that enhance biological discovery, emphasizing scalability and cost-efficiency.
How can I apply or pitch to Phase Capital?
Founders can pitch their ideas through the firm's website at phasecapital.co. It is recommended to include a clear business model, market analysis, and the team’s background in the pitch deck.
What makes Phase Capital different from other VC firms?
Phase Capital focuses specifically on the TechBio sector, combining biology, technology, and data. Their investment thesis emphasizes funding the infrastructure and people necessary to bring innovative technologies to market.
What is the geographic scope of Phase Capital's investments?
The firm primarily invests in early-stage companies located in the United States, with a particular focus on strengthening the Nashville biotech ecosystem.
What is the typical check size for investments?
While specific check sizes are not disclosed, Phase Capital typically invests at the pre-seed and seed stages, which generally involves smaller initial investments compared to later-stage funding.
What kind of post-investment involvement can founders expect?
Phase Capital provides support beyond capital, including funding for infrastructure, personnel, and experiments necessary for growth. They aim to be actively involved in helping portfolio companies succeed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.